Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

(2022) Christopher JL Murray et al.   LANCET

Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii

(2022) Marco Falcone et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

(2022) Pranita D. Tamma et al.   CLINICAL INFECTIOUS DISEASES

Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM)

(2022) Giusy Tiseo et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-nonsusceptible Enterobacterales collected as part of a Global Surveillance Program, 2012-2017

(2021) Krystyna M. Kazmierczak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Regional spread of blaNDM-1-containing Klebsiella pneumoniae ST147 in post-acute care facilities

(2021) Zena Lapp et al.   CLINICAL INFECTIOUS DISEASES

Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study)

(2021) Marco Falcone et al.   CLINICAL MICROBIOLOGY AND INFECTION

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)

(2021) Mical Paul et al.   CLINICAL MICROBIOLOGY AND INFECTION

Impact of carbapenem resistance on mortality in patients infected with Enterobacteriaceae: a systematic review and meta-analysis

(2021) Ruyin Zhou et al.   BMJ Open

Epidemiology of β-Lactamase-Producing Pathogens

(2020) Karen Bush et al.   CLINICAL MICROBIOLOGY REVIEWS

Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study

(2020) David van Duin et al.   LANCET INFECTIOUS DISEASES

Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase–Producing Enterobacterales During a Regional Outbreak

(2020) Marco Falcone et al.   Open Forum Infectious Diseases

Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL- producing Enterobacterales

(2020) Marco Falcone et al.   CLINICAL INFECTIOUS DISEASES

Cross-border spread of blaNDM-1- and blaOXA-48-positive Klebsiella pneumoniae: a European collaborative analysis of whole genome sequencing and epidemiological data, 2014 to 2019

(2020) Catherine Ludden et al.   Eurosurveillance

Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-Negative infections in ICU patients

(2020) Marco Falcone et al.   CLINICAL INFECTIOUS DISEASES

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

(2020) Theo Vos et al.   LANCET

Quantification and interpretation of attributable mortality in core clinical infectious disease journals

(2020) Maja von Cube et al.   LANCET INFECTIOUS DISEASES

Zero or more: methodological challenges of counting and estimating deaths related to antibiotic-resistant infections

(2019) Elizabeth Temkin et al.   CLINICAL INFECTIOUS DISEASES

Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study

(2019) Alessandro Russo et al.   JOURNAL OF INFECTION

A Cohort Study of the Impact of Carbapenem-Resistant Enterobacteriaceae Infections on Mortality of Patients Presenting with Sepsis

(2019) Sabrina Sabino et al.   mSphere

Resilience of the Pitt Bacteremia Score: Three Decades and Counting

(2019) Majdi N Al-Hasan et al.   CLINICAL INFECTIOUS DISEASES

The C-Word: Scientific Euphemisms Do Not Improve Causal Inference From Observational Data

(2018) Miguel A. Hernán   AMERICAN JOURNAL OF PUBLIC HEALTH

Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort

(2018) Marco Falcone et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy

(2018) Francesco Menichetti et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

(2018) Mical Paul et al.   LANCET INFECTIOUS DISEASES

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis

(2018) Alessandro Cassini et al.   LANCET INFECTIOUS DISEASES

Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase–producing K. pneumoniae

(2016) M. Falcone et al.   CLINICAL MICROBIOLOGY AND INFECTION

Infections with VIM-1 Metallo- -Lactamase-Producing Enterobacter cloacae and Their Correlation with Clinical Outcome

(2009) M. Falcone et al.   JOURNAL OF CLINICAL MICROBIOLOGY